FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

W Kuhn

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Physiology

Pregnancy

Anatomy

Ovaries

Co-author Network

Publications

TOP 3
W Kuhn; Stephan Rutke; K Späthe; Barbara Schmalfeldt; G Florack; B von Hundelshausen; D Pachyn; Kurt Ulm; Henner Graeff
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
Ernst Lengyel; Barbara Schmalfeldt; E Konik; K Späthe; K Härting; A Fenn; U Berger; Rafael Fridman; Manfred Schmitt; Dieter Prechtel; W Kuhn
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Barbara Schmalfeldt; Dieter Prechtel; K Härting; K Späthe; Stephan Rutke; E Konik; Rafael Fridman; U Berger; Manfred Schmitt; W Kuhn; Ernst Lengyel
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of W Kuhn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: W Kuhn; Stephan Rutke; K Späthe; Barbara Schmalfeldt; G Florack; B von Hundelshausen; D Pachyn; Kurt Ulm; Henner Graeff
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
Cancer 2001;92(10):2585-91.
2001: Ernst Lengyel; Barbara Schmalfeldt; E Konik; K Späthe; K Härting; A Fenn; U Berger; Rafael Fridman; Manfred Schmitt; Dieter Prechtel; W Kuhn
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Gynecologic oncology 2001;82(2):291-8.
2001: Barbara Schmalfeldt; Dieter Prechtel; K Härting; K Späthe; Stephan Rutke; E Konik; Rafael Fridman; U Berger; Manfred Schmitt; W Kuhn; Ernst Lengyel
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2396-404.
2000: M Schelling; M Braun; W Kuhn; G Bogner; R Gruber; J Gnirs; K T M Schneider; Kurt Ulm; Stephan Rutke; A Staudach
Combined transvaginal B-mode and color Doppler sonography for differential diagnosis of ovarian tumors: results of a multivariate logistic regression analysis.
Gynecologic oncology 2000;77(1):78-86.
1999: W Kuhn; Barbara Schmalfeldt; Ute Reuning; L Pache; U Berger; Kurt Ulm; Nadia Harbeck; K Späthe; P Dettmar; Heinz Höfler; Fritz Jänicke; Manfred Schmitt; Henner Graeff
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc.
British journal of cancer 1999;79(11-12):1746-51.
1999: Nadia Harbeck; J S Ross; S Yurdseven; P Dettmar; M Pölcher; W Kuhn; Kurt Ulm; Henner Graeff; Manfred Schmitt
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
International journal of oncology 1999;14(4):663-71.
1998: W Kuhn; Barbara Schmalfeldt; L Pache; K Späthe; Kurt Ulm; K Renziehausen; H Nöschel; E Canzler; B Richter; M Kroner; G Tilch; F Janicke; Henner Graeff
Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.
International journal of oncology 1998;13(1):57-63.
1996: W Kuhn; Barbara Schmalfeldt; Jörg Schwarz; L Pache; Kurt Ulm; K Freitag; Fritz Jänicke; Henner Graeff
-Intravenous or oral etoposide therapy of platinum refractory ovarian cancer with early recurrence. Results of a prospective randomized study-.
Geburtshilfe und Frauenheilkunde 1996;56(2):105-10.
1995: Barbara Schmalfeldt; W Kuhn; Ute Reuning; L Pache; P Dettmar; Manfred Schmitt; Fritz Jänicke; Heinz Höfler; Henner Graeff
Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.
Cancer research 1995;55(18):3958-63.
1994: W Kuhn; L Pache; Barbara Schmalfeldt; P Dettmar; Manfred Schmitt; Fritz Jänicke; Henner Graeff
Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.
Gynecologic oncology 1994;55(3 Pt 1):401-9.
1994: W Kuhn; W Loos; Henner Graeff
[Hydronephrosis as the first manifestation of primary metastatic breast cancer].
Geburtshilfe und Frauenheilkunde 1994;54(5):308-10.
1993: W Kuhn; Fritz Jänicke; L Pache; M Hölscher; G Schattenmann; Barbara Schmalfeldt; H Anderl; G Schüle; P Dettmar; J R Siewert
[Developments in the therapy of advanced FIGO III ovarian cancer].
Geburtshilfe und Frauenheilkunde 1993;53(5):293-302.
1992: Fritz Jänicke; M Hölscher; W Kuhn; R von Hugo; L Pache; J R Siewert; Henner Graeff
Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.
Cancer 1992;70(8):2129-36.
1991: W Kuhn; Fritz Jänicke; M Hölscher; G Schüle; L Pache; Henner Graeff
[Surgical treatment of ovarian cancer: comparison of primary and secondary tumor reduction interventions].
Gynäkologische Rundschau 1991;31 Suppl 2():276-80.
1991: Fritz Jänicke; W Kuhn; M Hölscher; Henner Graeff
[Secondary surgical interventions in ovarian cancer].
Gynäkologische Rundschau 1991;31 Suppl 2():26-34.
1991: R Deckardt; Fritz Jänicke; W Kuhn
[Therapy of tubal pregnancy with prostaglandin].
Gynäkologische Rundschau 1991;31 Suppl 2():346-8.
1990: R Deckardt; Fritz Jänicke; W Kuhn; G H Zhang
[Laparoscopic treatment of tubal pregnancy with prostaglandins].
Geburtshilfe und Frauenheilkunde 1990;50(7):533-7.
1989: W Loos; W Rath; R von Hugo; H Graeff; W Kuhn
[Septic ovarian vein thrombosis--diagnosis and therapy].
Archives of gynecology and obstetrics 1989;245(1-4):827-9.
1988: W Loos; R von Hugo; W Rath; B R Muck; M Albrecht; H Graeff; W Kuhn; J Zander
[Puerperal ovarian vein thrombophlebitis--a rare puerperal complication].
Geburtshilfe und Frauenheilkunde 1988;48(7):483-8.